Beijing Sun Novo Pharmaceutical Research Co Ltd (688621 SHG) stock market data APIs

¥53.0318 -3.42(-6.4%)
as of July 1, 2025
Try our APIs with free plan!

Beijing Sun Novo Pharmaceutical Research Co Ltd Financial Data Overview

Price chart is built with Anychart

Beijing Sun-Novo Pharmaceutical Research Co., Ltd., a contract research company, engages in the research and development of drugs in China. The company operates external preparation platform that focuses on the research and development of new drugs and generic drugs for skin external preparations; children's clinical data bridging research center; pediatric drug research and development platform; pediatric drug delivery dosage research and development platform; respiratory tract drug delivery and topical preparation platforms; polypeptide and other drug molecular design and development platform; genotoxic impurity detection platform; technology platform for slow and controlled release preparations; drug synthesis platform; and synthesis technology platform. It also offers SMO, clinical quality management, data management and statistical analysis, project management, test center, clinical research center, clinical trials, TMFDocument management, quality control, Medical Writing, medical monitoring, and pharmacovigilance services; and registration-related services for chemical drugs, biological products, and medical device products. In addition, the company operates quantitative pharmacology platform that use technology on pharmacokinetics, pharmacodynamics, body function, disease mechanism and test process, and other information for quantitative research; and mass spectrometry, immunological analysis, cell biology, and molecular biology platforms that provide biological analysis services for large and small molecular drugs, as well as operates as a Contract Research Organization for Professional Peptide Drug Research and Development. Beijing Sun-Novo Pharmaceutical Research Co., Ltd. was founded in 2009 and is based in Beijing, China.

Prev. Close 53.0318
Open 49.6151
High 53.7258
Low 49.6387
52 wk Range 28.8134-59.8004
Market Cap 5 990 M
P/E Ratio 44.9412
Shares Outstanding 112 M
Revenue 1 057 M
EPS 0.428
Dividends (Yield) 0.0033
Beta 0.307

Why to choose EODHD?

Prices start at $19.99

24/7 Live support

Robust, powerful and reliable data

API Simplicity of a few lines of code


Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW

Get Beijing Sun Novo Pharmaceutical Research Co Ltd data using free add-ons & libraries


Get Beijing Sun Novo Pharmaceutical Research Co Ltd Fundamental Data

Beijing Sun Novo Pharmaceutical Research Co Ltd Fundamental data includes:

  • Net Revenue: 1 057 M
  • EBITDA: 151 M
  • Earnings Per Share: 1
  • Income Statements
  • Balance Sheets
  • Cash flows

Plans with Fundamental data

Starting from

$ 59.99 /mo.
COMPARE PLANS

End-of-day & Earnings data

Get Beijing Sun Novo Pharmaceutical Research Co Ltd Earnings data

Calendar & News package for

$ 19.99 /mo.

What’s included:

  • Latest Release: 2023-04-27
  • EPS/Forecast: NaN
GET THE PACKAGE

Get Beijing Sun Novo Pharmaceutical Research Co Ltd End-of-day data

EOD Historical Data package for

$ 19.99 /mo.

What’s included:

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
GET THE PACKAGE
Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW
  • Flexibility: No long-term commitments, just a minimum of one month
  • Instant access: Get your API key and instructions within seconds of subscribing
  • Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.

What’s included:

  • API Calls per Day: 100 000/day
  • API Requests per Min.: 1000/minute
  • Type of Usage: Personal use

Data access:

Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.

GET THE PACKAGE
Chat